Human IgG Quick test strip |
|||
| E411A02-10 | EnoGene | 10 tests | EUR 150 |
Human IgG antibody Laboratories manufactures the antibody test sarscov2 reagents distributed by Genprice. The Antibody Test Sarscov2 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Test Group: Sarscov2
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
||
| Abbexa | 100 µl | EUR 225 |
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
||
| Abbexa | 1 ml | Ask for price |
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
||
| Abbexa | 200 µl | EUR 350 |
Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit |
||
| Abbexa | 100 µl | EUR 225 |
Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit |
||
| Abbexa | 1 ml | Ask for price |
Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit |
||
| Abbexa | 200 µl | EUR 350 |
NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
||
| Atlas Link Technology | 40 Tests | EUR 115 |
Anti SARS-Cov-2 Spike Mab |
|||
| 112056 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-Cov-2 Spike (RBD) Pab |
|||
| 112040 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-Cov-2 Spike (RBD) Mab |
|||
| 112057 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-CoV2-S (Rabbit) |
|||
| 134407 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-CoV2-N (Rabbit) |
|||
| 134408 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-CoV2-S (Mouse) Mab |
|||
| 134415 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-CoV2-N (Mouse) Mab |
|||
| 134416 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-CoV2-O (Mouse) Mab |
|||
| 134417 | Antibody Research Corporation | 100 µg | Ask for price |
SARS-CoV-2 Ag Rapid Test |
|||
| HSGIA2200A1COV | Hi-Senty | 20 Tests/Kit | Ask for price |
|
Description: The SARS-CoV-2 Ag Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in nasal swab specimens from individualswith suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests. Results are for the detection of SARS-CoV-2 Antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or coinfection with other viruses. The agent detected may not be the definite cause of disease. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions. Negative results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient management. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. The SARS-CoV-2 Ag Rapid Test is intended for use by self-testing personnel. |
|||
SARS-CoV-2 Rapid Antigen Test Nasal |
|||
| 9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | EUR 112.8 |
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
|||
Anti SARS-Cov-2 Orf8, Phosphatase Pab |
|||
| 112041 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-Cov-2 Nucleoprotein Mab |
|||
| 112044 | Antibody Research Corporation | 100 µg | Ask for price |
Anti SARS-Cov-2 Nucleoprotein Pab |
|||
| 272451 | Antibody Research Corporation | 100 µg | Ask for price |
SARS-CoV-2 IgM/IgG Antibody |
|||
| RT090A | Macro & Micro-Test Med-Tech | 1 Each | Ask for price |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|||
| abx294171-100g | Abbexa | 100 µg | EUR 1525 |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|||
| abx294171-20g | Abbexa | 20 µg | EUR 187.5 |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|||
| abx294171-50g | Abbexa | 50 µg | EUR 337.5 |
